GWAS data sets have identified one or more single nucleotide polymorphisms (SNPs) for other widely-reported circulating ILs in MS, such as IL-1 receptor antagonist (IL-1Ra), IL-2Rα, IL-6, IL-16, IL-17, and IL-18 (20–24). This evidence concerns the gene IL17A and myeloid sarcoma.